Click for best price
Oncology Based Molecular Diagnostic Market Size, Share 2022
This report contains market size and forecasts of Oncology Based Molecular Diagnostic in Global, including the following market information:
The global Oncology Based Molecular Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Instruments Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oncology Based Molecular Diagnostic include Abbott, Bayer Healthcare, Beckton Dickinson, Cepheid, Dako, Hologic, Qiagen, Roche and Siemens Healthineers and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oncology Based Molecular Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Based Molecular Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oncology Based Molecular Diagnostic Market Segment Percentages, by Type, 2021 (%)
Global Oncology Based Molecular Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oncology Based Molecular Diagnostic Market Segment Percentages, by Application, 2021 (%)
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Liver Cancer
- Lung Cancer
- Blood Cancer
- Kidney Cancer
Global Oncology Based Molecular Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oncology Based Molecular Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Oncology Based Molecular Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Oncology Based Molecular Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- Bayer Healthcare
- Beckton Dickinson
- Cepheid
- Dako
- Hologic
- Qiagen
- Roche
- Siemens Healthineers
- Sysmex
| Report Attributes |
Report Details |
| Report Title |
Oncology Based Molecular Diagnostic Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oncology Based Molecular Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Based Molecular Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Based Molecular Diagnostic Overall Market Size
2.1 Global Oncology Based Molecular Diagnostic Market Size: 2021 VS 2028
2.2 Global Oncology Based Molecular Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Based Molecular Diagnostic Players in Global Market
3.2 Top Global Oncology Based Molecular Diagnostic Companies Ranked by Revenue
3.3 Global Oncology Based Molecular Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Oncology Based Molecular Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oncology Based Molecular Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Based Molecular Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Oncology Based Molecular Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Based Molecular Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Oncology Based Molecular Diagnostic Market Size Markets, 2021 & 2028
4.1.2 Instruments
4.1.3 Reagents
4.2 By Type - Global Oncology Based Molecular Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Oncology Based Molecular Diagnostic Revenue, 2017-2022
4.2.2 By Type - Global Oncology Based Molecular Diagnostic Revenue, 2023-2028
4.2.3 By Type - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Based Molecular Diagnostic Market Size, 2021 & 2028
5.1.2 Breast Cancer
5.1.3 Prostate Cancer
5.1.4 Colorectal Cancer
5.1.5 Cervical Cancer
5.1.6 Liver Cancer
5.1.7 Lung Cancer
5.1.8 Blood Cancer
5.1.9 Kidney Cancer
5.2 By Application - Global Oncology Based Molecular Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Oncology Based Molecular Diagnostic Revenue, 2017-2022
5.2.2 By Application - Global Oncology Based Molecular Diagnostic Revenue, 2023-2028
5.2.3 By Application - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Oncology Based Molecular Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Oncology Based Molecular Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Oncology Based Molecular Diagnostic Revenue, 2017-2022
6.2.2 By Region - Global Oncology Based Molecular Diagnostic Revenue, 2023-2028
6.2.3 By Region - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Oncology Based Molecular Diagnostic Revenue, 2017-2028
6.3.2 US Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.3.3 Canada Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.3.4 Mexico Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Oncology Based Molecular Diagnostic Revenue, 2017-2028
6.4.2 Germany Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.4.3 France Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.4.4 U.K. Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.4.5 Italy Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.4.6 Russia Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.4.7 Nordic Countries Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.4.8 Benelux Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Oncology Based Molecular Diagnostic Revenue, 2017-2028
6.5.2 China Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.5.3 Japan Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.5.4 South Korea Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.5.5 Southeast Asia Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.5.6 India Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Oncology Based Molecular Diagnostic Revenue, 2017-2028
6.6.2 Brazil Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.6.3 Argentina Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Based Molecular Diagnostic Revenue, 2017-2028
6.7.2 Turkey Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.7.3 Israel Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.7.4 Saudi Arabia Oncology Based Molecular Diagnostic Market Size, 2017-2028
6.7.5 UAE Oncology Based Molecular Diagnostic Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Oncology Based Molecular Diagnostic Major Product Offerings
7.1.4 Abbott Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporate Summary
7.2.2 Bayer Healthcare Business Overview
7.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Major Product Offerings
7.2.4 Bayer Healthcare Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.2.5 Bayer Healthcare Key News
7.3 Beckton Dickinson
7.3.1 Beckton Dickinson Corporate Summary
7.3.2 Beckton Dickinson Business Overview
7.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Major Product Offerings
7.3.4 Beckton Dickinson Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.3.5 Beckton Dickinson Key News
7.4 Cepheid
7.4.1 Cepheid Corporate Summary
7.4.2 Cepheid Business Overview
7.4.3 Cepheid Oncology Based Molecular Diagnostic Major Product Offerings
7.4.4 Cepheid Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.4.5 Cepheid Key News
7.5 Dako
7.5.1 Dako Corporate Summary
7.5.2 Dako Business Overview
7.5.3 Dako Oncology Based Molecular Diagnostic Major Product Offerings
7.5.4 Dako Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.5.5 Dako Key News
7.6 Hologic
7.6.1 Hologic Corporate Summary
7.6.2 Hologic Business Overview
7.6.3 Hologic Oncology Based Molecular Diagnostic Major Product Offerings
7.6.4 Hologic Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.6.5 Hologic Key News
7.7 Qiagen
7.7.1 Qiagen Corporate Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Oncology Based Molecular Diagnostic Major Product Offerings
7.7.4 Qiagen Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.7.5 Qiagen Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Oncology Based Molecular Diagnostic Major Product Offerings
7.8.4 Roche Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.8.5 Roche Key News
7.9 Siemens Healthineers
7.9.1 Siemens Healthineers Corporate Summary
7.9.2 Siemens Healthineers Business Overview
7.9.3 Siemens Healthineers Oncology Based Molecular Diagnostic Major Product Offerings
7.9.4 Siemens Healthineers Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.9.5 Siemens Healthineers Key News
7.10 Sysmex
7.10.1 Sysmex Corporate Summary
7.10.2 Sysmex Business Overview
7.10.3 Sysmex Oncology Based Molecular Diagnostic Major Product Offerings
7.10.4 Sysmex Oncology Based Molecular Diagnostic Revenue in Global Market (2017-2022)
7.10.5 Sysmex Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oncology Based Molecular Diagnostic Market Opportunities & Trends in Global Market
Table 2. Oncology Based Molecular Diagnostic Market Drivers in Global Market
Table 3. Oncology Based Molecular Diagnostic Market Restraints in Global Market
Table 4. Key Players of Oncology Based Molecular Diagnostic in Global Market
Table 5. Top Oncology Based Molecular Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oncology Based Molecular Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oncology Based Molecular Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oncology Based Molecular Diagnostic Product Type
Table 9. List of Global Tier 1 Oncology Based Molecular Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Based Molecular Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oncology Based Molecular Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oncology Based Molecular Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oncology Based Molecular Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oncology Based Molecular Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oncology Based Molecular Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oncology Based Molecular Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Oncology Based Molecular Diagnostic Product Offerings
Table 32. Abbott Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Healthcare Corporate Summary
Table 34. Bayer Healthcare Oncology Based Molecular Diagnostic Product Offerings
Table 35. Bayer Healthcare Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Beckton Dickinson Corporate Summary
Table 37. Beckton Dickinson Oncology Based Molecular Diagnostic Product Offerings
Table 38. Beckton Dickinson Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Cepheid Corporate Summary
Table 40. Cepheid Oncology Based Molecular Diagnostic Product Offerings
Table 41. Cepheid Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Dako Corporate Summary
Table 43. Dako Oncology Based Molecular Diagnostic Product Offerings
Table 44. Dako Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Hologic Corporate Summary
Table 46. Hologic Oncology Based Molecular Diagnostic Product Offerings
Table 47. Hologic Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Qiagen Corporate Summary
Table 49. Qiagen Oncology Based Molecular Diagnostic Product Offerings
Table 50. Qiagen Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Oncology Based Molecular Diagnostic Product Offerings
Table 53. Roche Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Siemens Healthineers Corporate Summary
Table 55. Siemens Healthineers Oncology Based Molecular Diagnostic Product Offerings
Table 56. Siemens Healthineers Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Sysmex Corporate Summary
Table 58. Sysmex Oncology Based Molecular Diagnostic Product Offerings
Table 59. Sysmex Oncology Based Molecular Diagnostic Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Oncology Based Molecular Diagnostic Segment by Type in 2021
Figure 2. Oncology Based Molecular Diagnostic Segment by Application in 2021
Figure 3. Global Oncology Based Molecular Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oncology Based Molecular Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oncology Based Molecular Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Based Molecular Diagnostic Revenue in 2021
Figure 8. By Type - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oncology Based Molecular Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oncology Based Molecular Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Healthcare Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Beckton Dickinson Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cepheid Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Dako Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hologic Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Qiagen Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Siemens Healthineers Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sysmex Oncology Based Molecular Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
